{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:21Z","timestamp":1790294421514,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFA1104900"],"award-info":[{"award-number":["2022YFA1104900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03290-5","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T02:26:23Z","timestamp":1742610383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Microalgae-based biodegradable embolic agent for the treatment of hepatocellular carcinoma through transarterial embolization"],"prefix":"10.1186","volume":"23","author":[{"given":"Kaiyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qitao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"3290_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3290_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","volume":"3","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, et al. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer. 2022;3:386\u2013401.","journal-title":"Nat Cancer"},{"key":"3290_CR3","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1200\/JCO.2010.28.7805","volume":"28","author":"MB Thomas","year":"2010","unstructured":"Thomas MB, et al. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute clinical trials planning meeting. JCO. 2010;28:3994\u20134005.","journal-title":"JCO"},{"key":"3290_CR4","doi-asserted-by":"publisher","first-page":"e007366","DOI":"10.1136\/jitc-2023-007366","volume":"11","author":"W Zhang","year":"2023","unstructured":"Zhang W, et al. Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial. J Immunother Cancer. 2023;11:e007366.","journal-title":"J Immunother Cancer"},{"key":"3290_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3350\/cmh.2022.0402","volume":"29","author":"D Xie","year":"2023","unstructured":"Xie D, Shi J, Zhou J, Fan J, Gao Q. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective. Clin Mol Hepatol. 2023;29:206\u201316.","journal-title":"Clin Mol Hepatol"},{"key":"3290_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41575-020-00395-0","volume":"18","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2021;18:293\u2013313.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3290_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","volume":"72","author":"J-L Raoul","year":"2019","unstructured":"Raoul J-L, et al. Updated use of TACE for hepatocellular carcinoma treatment: how and when to use it based on clinical evidence. Cancer Treat Rev. 2019;72:28\u201336.","journal-title":"Cancer Treat Rev"},{"key":"3290_CR8","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jconrel.2012.01.018","volume":"161","author":"AL Lewis","year":"2012","unstructured":"Lewis AL, Dreher MR. Locoregional drug delivery using image-guided intra-arterial drug eluting bead therapy. J Controlled Release. 2012;161:338\u201350.","journal-title":"J Controlled Release"},{"key":"3290_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/cancers16010071","volume":"16","author":"M Szemitko","year":"2023","unstructured":"Szemitko M, Falkowski A, Modrzejewska M, Golubinska-Szemitko E. Efficacy and safety of liver chemoembolization procedures, combined with FOLFIRI chemotherapy, in First-Line treatment of metastatic colorectal Cancer in patients with oncogene mutations. Cancers (Basel). 2023;16:71.","journal-title":"Cancers (Basel)"},{"key":"3290_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.5582\/bst.2019.01153","volume":"13","author":"T Han","year":"2019","unstructured":"Han T, et al. The clinical safety and efficacy of conventional transcatheter arterial chemoembolization and drug-eluting beads-transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis. Biosci Trends. 2019;13:374\u201381.","journal-title":"Biosci Trends"},{"key":"3290_CR11","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1007\/s00261-019-02349-w","volume":"45","author":"J Grumme","year":"2020","unstructured":"Grumme J, et al. Transarterial chemoembolization for hepatocellular carcinoma: quality of life, tumour response, safety and survival comparing two types of drug-eluting beads. Abdom Radiol. 2020;45:3326\u201336.","journal-title":"Abdom Radiol"},{"key":"3290_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0168-8278(00)80100-2","volume":"32","author":"PC Kwok","year":"2000","unstructured":"Kwok PC, et al. A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma. J Hepatol. 2000;32:955\u201364.","journal-title":"J Hepatol"},{"key":"3290_CR13","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/cells10071715","volume":"10","author":"MH-R Bao","year":"2021","unstructured":"Bao MH-R, Wong CC-L, Hypoxia. Metabolic reprogramming, and drug resistance in liver Cancer. Cells. 2021;10:1715.","journal-title":"Cells"},{"key":"3290_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12951-023-01820-7","volume":"21","author":"G Yuan","year":"2023","unstructured":"Yuan G, et al. Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma. J Nanobiotechnol. 2023;21:68.","journal-title":"J Nanobiotechnol"},{"key":"3290_CR15","doi-asserted-by":"publisher","first-page":"2011170","DOI":"10.1002\/adfm.202011170","volume":"31","author":"Q Wang","year":"2021","unstructured":"Wang Q, et al. Precision embolism: biocompatible Temperature-Sensitive hydrogels as novel embolic materials for both mainstream and peripheral vessels. Adv Funct Mater. 2021;31:2011170.","journal-title":"Adv Funct Mater"},{"key":"3290_CR16","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.7150\/thno.27379","volume":"8","author":"J Zeng","year":"2018","unstructured":"Zeng J, et al. Radiopaque and uniform alginate microspheres loaded with tantalum nanoparticles for real-time imaging during transcatheter arterial embolization. Theranostics. 2018;8:4591\u2013600.","journal-title":"Theranostics"},{"key":"3290_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jbiotec.2022.10.009","volume":"360","author":"S Sampath","year":"2022","unstructured":"Sampath S, et al. A review on algal mediated synthesis of metal and metal oxide nanoparticles and their emerging biomedical potential. J Biotechnol. 2022;360:92\u2013109.","journal-title":"J Biotechnol"},{"key":"3290_CR18","doi-asserted-by":"publisher","first-page":"127691","DOI":"10.1016\/j.ijbiomac.2023.127691","volume":"254","author":"L Vazquez-Ayala","year":"2024","unstructured":"Vazquez-Ayala L, et al. Chitosan sponges loaded with Metformin and microalgae as dressing for wound healing: A study in diabetic bio-models. Int J Biol Macromol. 2024;254:127691.","journal-title":"Int J Biol Macromol"},{"key":"3290_CR19","doi-asserted-by":"publisher","first-page":"127811","DOI":"10.1016\/j.ijbiomac.2023.127811","volume":"254","author":"S Li","year":"2024","unstructured":"Li S, Guo W, Zhang M, Zeng M, Wu H. Microalgae polysaccharides exert antioxidant and anti-inflammatory protective effects on human intestinal epithelial cells in vitro and dextran sodium sulfate-induced mouse colitis in vivo. Int J Biol Macromol. 2024;254:127811.","journal-title":"Int J Biol Macromol"},{"key":"3290_CR20","doi-asserted-by":"publisher","first-page":"10560","DOI":"10.1021\/acsnano.3c01502","volume":"17","author":"D Zhang","year":"2023","unstructured":"Zhang D, et al. Oral Microalgae-Nano integrated system against Radiation-Induced injury. ACS Nano. 2023;17:10560\u201376.","journal-title":"ACS Nano"},{"key":"3290_CR21","doi-asserted-by":"crossref","unstructured":"Rao A, Briskey D, Nalley JO, Ganuza E. Omega-3 Eicosapentaenoic Acid (EPA) Rich Extract from the Microalga Nannochloropsis Decreases Cholesterol in Healthy Individuals: A Double-Blind, Randomized, Placebo-Controlled, Three-Month Supplementation Study. Nutrients. 2020;12:1869.","DOI":"10.3390\/nu12061869"},{"key":"3290_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/nu10040522","volume":"10","author":"S Davinelli","year":"2018","unstructured":"Davinelli S, Nielsen ME, Scapagnini G. Astaxanthin in skin health, repair, and disease: A comprehensive review. Nutrients. 2018;10:522.","journal-title":"Nutrients"},{"key":"3290_CR23","doi-asserted-by":"publisher","first-page":"105479","DOI":"10.1016\/j.phrs.2021.105479","volume":"166","author":"A Donoso","year":"2021","unstructured":"Donoso A, Gonz\u00e1lez-Dur\u00e1n J, Mu\u00f1oz AA, Gonz\u00e1lez PA, Agurto-Mu\u00f1oz C. Therapeutic uses of natural Astaxanthin: an evidence-based review focused on human clinical trials. Pharmacol Res. 2021;166:105479.","journal-title":"Pharmacol Res"},{"key":"3290_CR24","doi-asserted-by":"publisher","first-page":"122263","DOI":"10.1016\/j.biomaterials.2023.122263","volume":"301","author":"X Sun","year":"2023","unstructured":"Sun X, et al. A tumor microenvironment-activatable nanoplatform with phycocyanin-assisted in-situ nanoagent generation for synergistic treatment of colorectal cancer. Biomaterials. 2023;301:122263.","journal-title":"Biomaterials"},{"key":"3290_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ijbiomac.2015.09.039","volume":"81","author":"R Pan","year":"2015","unstructured":"Pan R, et al. Spirulina phycocyanin induces differential protein expression and apoptosis in SKOV-3 cells. Int J Biol Macromol. 2015;81:951\u20139.","journal-title":"Int J Biol Macromol"},{"key":"3290_CR26","doi-asserted-by":"publisher","first-page":"142654","DOI":"10.1016\/j.scitotenv.2020.142654","volume":"755","author":"F Almomani","year":"2021","unstructured":"Almomani F, Bhosale RR. Bio-sorption of toxic metals from industrial wastewater by algae strains Spirulina platensis and Chlorella vulgaris: application of isotherm, kinetic models and process optimization. Sci Total Environ. 2021;755:142654.","journal-title":"Sci Total Environ"},{"key":"3290_CR27","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1080\/10717544.2021.1943057","volume":"28","author":"G Zhao","year":"2021","unstructured":"Zhao G, et al. Assessment of efficacy and safety by callispheres versus hepaspheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients. Drug Deliv. 2021;28:1356\u201362.","journal-title":"Drug Deliv"},{"key":"3290_CR28","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.7150\/thno.80213","volume":"13","author":"D Wang","year":"2023","unstructured":"Wang D, Rao W. Bench-to-bedside development of multifunctional flexible embolic agents. Theranostics. 2023;13:2114\u201339.","journal-title":"Theranostics"},{"key":"3290_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.62476\/abes93311","volume":"9","author":"R Khalilov","year":"2024","unstructured":"Khalilov R, et al. Interactions of nanoparticles and biological systems. ABES. 2024;9:311\u20138.","journal-title":"ABES"},{"key":"3290_CR30","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.2174\/1871520617666170327155930","volume":"17","author":"E Ahmadian","year":"2017","unstructured":"Ahmadian E, et al. Anti-cancer effects of Citalopram on hepatocellular carcinoma cells occur via cytochrome C release and the activation of NF-kB. Anticancer Agents Med Chem. 2017;17:1570\u20137.","journal-title":"Anticancer Agents Med Chem"},{"key":"3290_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00535-010-0306-5","volume":"46","author":"T Yamasaki","year":"2011","unstructured":"Yamasaki T, et al. A novel transcatheter arterial infusion chemotherapy using Iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial. J Gastroenterol. 2011;46:359\u201366.","journal-title":"J Gastroenterol"},{"key":"3290_CR32","doi-asserted-by":"publisher","first-page":"111949","DOI":"10.1016\/j.msec.2021.111949","volume":"122","author":"Z Dong","year":"2021","unstructured":"Dong Z, et al. Progress of gelatin-based microspheres (GMSs) as delivery vehicles of drug and cell. Mater Sci Engineering: C. 2021;122:111949.","journal-title":"Mater Sci Engineering: C"},{"key":"3290_CR33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.cej.2019.03.221","volume":"370","author":"Q-W Cai","year":"2019","unstructured":"Cai Q-W, et al. Fabrication and flow characteristics of monodisperse bullet-shaped microparticles with controllable structures. Chem Eng J. 2019;370:925\u201337.","journal-title":"Chem Eng J"},{"key":"3290_CR34","doi-asserted-by":"publisher","first-page":"e2102281","DOI":"10.1002\/adhm.202102281","volume":"11","author":"Y Luo","year":"2022","unstructured":"Luo Y, et al. Shape-Anisotropic microembolics generated by microfluidic synthesis for transarterial embolization treatment. Adv Healthc Mater. 2022;11:e2102281.","journal-title":"Adv Healthc Mater"},{"key":"3290_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jconrel.2022.08.015","volume":"350","author":"J Liu","year":"2022","unstructured":"Liu J, et al. Polymersome-stabilized doxorubicin-lipiodol emulsions for high-efficacy chemoembolization therapy. J Control Release. 2022;350:122\u201331.","journal-title":"J Control Release"},{"key":"3290_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.62476\/abes93330","volume":"9","author":"Nasibova","year":"2024","unstructured":"Nasibova. The modern perspectives of nanomaterial applications in cancer treatment and drug delivery. ABES. 2024;9:330\u20137.","journal-title":"ABES"},{"key":"3290_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.62476\/abes9s81","volume":"9","author":"E Huseynov","year":"2024","unstructured":"Huseynov E, et al. Novel nanomaterials for hepatobiliary diseases treatment and future perspectives. ABES. 2024;9:81\u201391.","journal-title":"ABES"},{"key":"3290_CR38","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1148\/radiol.2016152510","volume":"281","author":"J Li","year":"2016","unstructured":"Li J, et al. Hepatocellular carcinoma: Intra-arterial delivery of Doxorubicin-loaded Hollow gold nanospheres for photothermal Ablation-Chemoembolization therapy in rats. Radiology. 2016;281:427\u201335.","journal-title":"Radiology"},{"key":"3290_CR39","doi-asserted-by":"publisher","first-page":"e2203915","DOI":"10.1002\/adma.202203915","volume":"34","author":"R Cheng","year":"2022","unstructured":"Cheng R, et al. A pH-Responsive cluster Metal-Organic framework nanoparticle for enhanced tumor accumulation and antitumor effect. Adv Mater. 2022;34:e2203915.","journal-title":"Adv Mater"},{"key":"3290_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","volume":"38","author":"P Icard","year":"2018","unstructured":"Icard P, et al. How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat. 2018;38:1\u201311.","journal-title":"Drug Resist Updat"},{"key":"3290_CR41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s42255-022-00730-6","volume":"5","author":"H Cheng","year":"2023","unstructured":"Cheng H, et al. Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness. Nat Metab. 2023;5:314\u201330.","journal-title":"Nat Metab"},{"key":"3290_CR42","doi-asserted-by":"publisher","first-page":"eade5686","DOI":"10.1126\/sciimmunol.ade5686","volume":"7","author":"S Gaggero","year":"2022","unstructured":"Gaggero S, et al. IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective Mutein. Sci Immunol. 2022;7:eade5686.","journal-title":"Sci Immunol"},{"key":"3290_CR43","doi-asserted-by":"publisher","first-page":"5548","DOI":"10.1021\/acsbiomaterials.9b01181","volume":"5","author":"H Wu","year":"2019","unstructured":"Wu H, et al. Effects of environmental pH on macrophage polarization and osteoimmunomodulation. ACS Biomater Sci Eng. 2019;5:5548\u201357.","journal-title":"ACS Biomater Sci Eng"},{"key":"3290_CR44","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","volume":"28","author":"Y Su","year":"2021","unstructured":"Su Y, et al. PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug Delivery. 2021;28:1397\u2013418.","journal-title":"Drug Delivery"},{"key":"3290_CR45","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu L, et al. Tumor aerobic Glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1. Cell Metab. 2023;35:1580\u2013e15969.","journal-title":"Cell Metab"},{"key":"3290_CR46","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-10-2828","volume":"71","author":"F V\u00e9gran","year":"2011","unstructured":"V\u00e9gran F, Boidot R, Michiels C, Sonveaux P, Feron O. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-\u03baB\/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 2011;71:2550\u201360.","journal-title":"Cancer Res"},{"key":"3290_CR47","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","volume":"43","author":"P Apostolova","year":"2022","unstructured":"Apostolova P, Pearce EL. Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment. Trends Immunol. 2022;43:969\u201377.","journal-title":"Trends Immunol"},{"key":"3290_CR48","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s43018-022-00470-2","volume":"3","author":"F Cappellesso","year":"2022","unstructured":"Cappellesso F, et al. Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer. Nat Cancer. 2022;3:1464\u201383.","journal-title":"Nat Cancer"},{"key":"3290_CR49","doi-asserted-by":"crossref","unstructured":"Dong Z et al. Tumor Microenvironment Modulating CaCO3-Based Colloidosomal Microreactors Can Generally Reinforce Cancer Immunotherapy. Adv Mater. 2023:e2308254.","DOI":"10.1002\/adma.202308254"},{"key":"3290_CR50","doi-asserted-by":"publisher","first-page":"12964","DOI":"10.1021\/acsnano.2c05408","volume":"16","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. Arginine supplementation targeting tumor-Killing immune cells reconstructs the tumor microenvironment and enhances the antitumor immune response. ACS Nano. 2022;16:12964\u201378.","journal-title":"ACS Nano"},{"key":"3290_CR51","doi-asserted-by":"publisher","first-page":"e2100748","DOI":"10.1002\/adhm.202100748","volume":"10","author":"A Zhang","year":"2021","unstructured":"Zhang A, et al. CaCO3-Encapuslated microspheres for enhanced transhepatic arterial embolization treatment of hepatocellular carcinoma. Adv Healthc Mater. 2021;10:e2100748.","journal-title":"Adv Healthc Mater"},{"key":"3290_CR52","doi-asserted-by":"publisher","first-page":"126456","DOI":"10.1016\/j.biortech.2021.126456","volume":"346","author":"G Rosero-Chasoy","year":"2022","unstructured":"Rosero-Chasoy G, et al. Growth kinetics and quantification of carbohydrate, protein, lipids, and chlorophyll of Spirulina platensis under aqueous conditions using different carbon and nitrogen sources. Bioresour Technol. 2022;346:126456.","journal-title":"Bioresour Technol"},{"key":"3290_CR53","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.7150\/jca.21058","volume":"8","author":"L Jiang","year":"2017","unstructured":"Jiang L, et al. Phycocyanin: A potential drug for Cancer treatment. J Cancer. 2017;8:3416\u201329.","journal-title":"J Cancer"},{"key":"3290_CR54","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/j.ijbiomac.2021.11.064","volume":"193","author":"TJ Ashaolu","year":"2021","unstructured":"Ashaolu TJ, et al. Phycocyanin, a super functional ingredient from algae; properties, purification characterization, and applications. Int J Biol Macromol. 2021;193:2320\u201331.","journal-title":"Int J Biol Macromol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03290-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03290-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:37:12Z","timestamp":1742863032000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03290-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3290"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03290-5","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"30 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental involving animals were approved by the Experimental Animal Ethics Committee of the fourth affiliated hospital Zhejiang University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"234"}}